IBOGF (Universal Ibogaine) Change In Receivables: $-0.28 Mil (TTM As of Apr. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Universal Ibogaine Change In Receivables?

Universal Ibogaine IBOGF -13.04% Change In Receivables is $-0.28 Mil as of Apr. 2025.

Universal Ibogaine's change in receivables for the quarter that ended in Apr. 2025 was $-0.30 Mil. It means Universal Ibogaine's Accounts Receivable increased by $0.30 Mil from Jan. 2025 to Apr. 2025 .

Universal Ibogaine's change in receivables for the fiscal year that ended in Jul. 2024 was $-0.09 Mil. It means Universal Ibogaine's Accounts Receivable increased by $0.09 Mil from Jul. 2023 to Jul. 2024 .

Universal Ibogaine's Accounts Receivable for the quarter that ended in Apr. 2025 was $0.44 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Universal Ibogaine's Days Sales Outstanding for the three months ended in Apr. 2025 was 79.23.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Universal Ibogaine's liquidation value for the three months ended in Apr. 2025 was $-2.25 Mil.

Universal Ibogaine  (OTCPK:IBOGF) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Universal Ibogaine's Days Sales Outstanding for the quarter that ended in Apr. 2025 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=0.435/0.501*91
=79.23

2. In Ben Graham's calculation of liquidation value, Universal Ibogaine's accounts receivable are only considered to be worth 75% of book value:

Universal Ibogaine's liquidation value for the quarter that ended in Apr. 2025 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=0.092-2.671+0.75 * 0.435+0.5 * 0
=-2.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Universal Ibogaine Change In Receivables Related Terms

Universal Ibogaine Change In Receivables Historical Data

* Premium members only.

The historical data trend for Universal Ibogaine's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Universal Ibogaine Change In Receivables Chart

Universal Ibogaine Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Jul22 Jul23 Jul24
Change In Receivables
Get a 7-Day Free Trial -0.00 -0.01 0.00 0.12 -0.09

Universal Ibogaine Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.02 0.04 -0.03 -0.30

Universal Ibogaine Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Apr. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.28 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Receivables →
What does a Change In Receivables of $-0.28 Mil mean?
Universal Ibogaine (IBOGF) has a Change In Receivables of $-0.28 Mil as of Apr. 2025. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Universal Ibogaine and its competitors.
Is Universal Ibogaine's Change In Receivables too high?
Universal Ibogaine's current Change In Receivables is $-0.28 Mil.
How does Universal Ibogaine's Change In Receivables compare to LABT and CALC?
Universal Ibogaine's Change In Receivables of $-0.28 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Biotechnology company?
A good Change In Receivables depends on the Biotechnology industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Universal Ibogaine and its competitors. Universal Ibogaine's current Change In Receivables is $-0.28 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Universal Ibogaine stock overvalued right now?
Universal Ibogaine (IBOGF) has a current Change In Receivables of $-0.28 Mil. The current Change In Receivables is $-0.28 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For Universal Ibogaine (IBOGF), the current Change In Receivables is $-0.28 Mil as of Apr. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Universal Ibogaine Business Description

Address C/o Cas Corporate Governance Services Inc, 815 - 8th Avenue South west, Suite 600, Calgary, AB, CAN, T2P 3P2
Universal Ibogaine Inc is in the initial stages of implementing and financing its business plan, which is to develop a network of addiction treatment clinics and to undertake a planned clinical trial for research in Canada into the use of ibogaine, a natural plant-based substance, for addiction treatment. Its mission is to redefine the addiction recovery experience, providing those living with addiction the best possible recovery.